CN Stock MarketDetailed Quotes

000028 China National Accord Medicines Corporation

Watchlist
  • 30.03
  • -0.77-2.50%
Market Closed Dec 13 15:00 CST
16.71BMarket Cap11.33P/E (TTM)

About China National Accord Medicines Corporation Company

In the field of pharmaceutical distribution, the company is based on building an “excellent medical supply chain solution and service provider” to form a strong commercial network in southern China with integrated and large-scale industrial advantages. The company's main business includes pharmaceutical distribution and pharmaceutical retail. Corporate honors: China's AAA credit enterprise; Guangdong Province's top 500 enterprises in 2018; Guangdong Province's priority independent brands in 2018; famous brands in Shenzhen, etc.

Company Profile

Short Name-A国药一致
Symbol-A000028
Short Name-B一致B
Symbol-B200028
Company NameChina National Accord Medicines Corporation Ltd.
Listing DateAug 9, 1993
Issue Price3.50
Shares Offered30.00M share(s)
FoundedAug 2, 1986
Listed ExchangeSZ Stock Exchange
Legal Representativeyijian wu
General Managerjinxiong li
Secretarychuan li
Accounting FirmTianjian Certified Public Accountants (Special General Partnership)
Securities Representativezhaoyu wang
Legal CounselBeijing Deheng (Shenzhen) Law Firm
Employees120
Phone0755-25875152
Office AddressYonghe Pharmaceutical Building, No. 15, Baguasi Road, Yuanling Street, Futian District, Shenzhen, Guangdong
Zip Code518029
Registered AddressYonghe Pharmaceutical Building, No. 15, Baguasi Road, Yuanling Street, Futian District, Shenzhen, Guangdong
Fax0755-25195435
Emailgyyz0028@sinopharm.com
Websitehttp://www.szaccord.com.cn
Business License440301103040048
BusinessWholesale of Chinese medicine tablets, proprietary Chinese medicines, chemical raw materials, chemical preparations, antibiotic preparations, biochemicals, biological products (including vaccines and in vitro diagnostic reagents), second-class psychotropic drugs (preparations), narcotics, first-class psychotropic drugs (regional wholesale enterprises), medical toxic drugs, anabolic agents, peptide hormones; health food management; pharmaceutical packaging materials and pharmaceutical industry products research and development, consulting services; investment and establishment of businesses (specific projects are declared separately in China); Commerce, material supply and marketing industry (excluding franchised, specially controlled and exclusive products); ambulances Sales; supply chain management; warehousing agency services; logistics agency services; road cargo transportation agents; handling; transport cargo packaging services; other warehousing (excluding crude oil, refined oil storage, gas storage, dangerous goods storage); conference and exhibition services; all first-class medical devices; all Class II medical devices (including Class II in vitro diagnostic reagents); Class III: 6840 in vitro diagnostic reagents, 6807 thoracic cardiovascular surgical instruments, 6815 injection-puncture, 6821 medical electronic instruments, 6822 medical instruments, optical instruments and endoscopic equipment, 6823 medical ultrasound instruments and related equipment, 6824 medical laser equipment, 6825 medical high-frequency instruments and equipment, 6826 physical therapy and rehabilitation equipment, 6828 medical magnetic resonance equipment, 6830 medical X-ray equipment, 6832 medical high-energy radiation equipment, 6833 medical nuclide equipment, 6834 medical radiation protective equipment, 6840 clinical testing and analysis instruments, 6845 extracorporeal circulation and blood treatment equipment, 6846 implant materials and artificial organs, 6854 operating room, emergency room, treatment room equipment and instruments, 6858 medical Cold therapy, low temperature, refrigeration equipment and appliances, 6863 dental materials, 6864 medical hygiene materials and dressings, 6865 medical suture materials and adhesives, 6866 medical polymer materials and products, 6870 software, 6877 interventional equipment; pre-packaged food sales (excluding refrigerated frozen food), special food sales (health food sales, sales of formula for special medical purposes, sales of infant formula, sales of other infant formula). Operate import and export business (except for projects prohibited by law, administrative regulations, or decisions of the State Council; restricted projects must obtain permission before operating). Housing leasing, property management services.

Company Executives

  • Name
  • Position
  • Salary
  • yijian wu
  • Chairman, Directors, Nomination Committee Members, Strategy Committee Convener
  • --
  • jinxiong li
  • Directors, General Manager, Member of the Legal Compliance Committee, Strategy Committee Members
  • --
  • xian luo
  • Directors
  • --
  • honghai li
  • Independent Directors, Strategy Committee Members, Member of the Remuneration and Assessment Committee, Nomination Committee Convener
  • --
  • yalin bi
  • Independent Directors, Strategy Committee Members, Legal Compliance Committee Convener, Internal Risk Control and Audit Committee Member
  • --
  • bailing jiang
  • Independent Directors, Convener of Risk Internal Control and Audit Committee, Member of the Legal Compliance Committee
  • --
  • weiwei su
  • Independent Directors, Nomination Committee Members, Remuneration and Assessment Committee Convener
  • 250.00K
  • chuan li
  • Board Secretary, Deputy General Manager
  • --
  • zhaoyu wang
  • Securities Affairs Representative
  • --
  • deyong wen
  • Chairman of the Supervisory Board, Auditors
  • --
  • haiqing lu
  • Auditors
  • --
  • guolin gu
  • Deputy General Manager, Chief Financial Officer, General Counsel, Chief Compliance Officer
  • 1.66M
  • changbing chen
  • Deputy General Manager
  • 1.66M
  • xiaoyun xu
  • Employee Supervisors
  • --
Heat List
CN
Overall
Symbol
Price
% Chg

No Data

Investment Theme State-owned Enterprise Reform
State-owned Enterprise Reform
Intraday-1.75%
Cold Chain Logistics
Cold Chain Logistics
Intraday-1.82%
Monoclonal Antibody Concept
Monoclonal Antibody Concept
Intraday-1.90%